Mundipharma’s history began when the first entity was established in Switzerland in 1957 – the first of many. Since then Mundipharma has created a strong legacy, dedicated to alleviating human suffering and improving quality of life for patients.
Our patient-centric approach is supported by innovation, enabling scientific breakthroughs that result in better medicines. In addition, our entrepreneurial spirit has enabled us to grow, and in doing so, increase the number of patients we can reach.
With our regional emerging markets hub in Singapore, offices in countries across Asia Pacific, Latin America, the Middle East and Africa, and a global network, our medicines now touch the lives of patients in 128 countries in six continents.
As a network of independent associated companies, we are able to put patients at the heart of everything we do. This includes a commitment to providing affordable treatment, and focussing on specialist therapy areas in which we can make the most difference:
Mundipharma has an ever-increasing portfolio of 38 medicines. Three are on the World Health Organisation’s List of Critical Medicines, including BETADINE®. Trusted by hospitals, doctors and patients around the world, it has been proven by in-vitro studies to kill viruses associated with diseases including Ebola, MERS, SARS, Influenza and Hand Foot and Mouth Disease. Mundipharma actively works to help prevent the spread of diseases, including donating enough BETADINE® for two million hand washes during the Ebola outbreak in West Africa in 2014.
R&D and Manufacturing
Mundipharma’s R&D is led from research centres in Singapore, USA, UK, Germany, China and
Japan. We carry out pre-clinical research, pharmaceutical development, clinical development, drug safety, regulatory affairs and scientific support of new treatments.
Mundipharma leverages a network of world-class manufacturing facilities and medicine supply activities in the United States, Europe, Canada, Asia, Middle East, Africa, Latin America, Australia, and New Zealand. The network has nine internal manufacturing/supply locations and benefits from vertical integration.
Mundipharma is focussed on creating new, transformative ways to help doctors and patients, and developing innovative new medicines to meet future healthcare challenges. We are also working to improve patient access to essential medication, and doctor education, in underdeveloped areas.
Mundipharma will always be focused on improving patients’ quality of life.
Read more at www.mundipharma.com.sg
Mundipharma Pharmaceuticals Pte Ltd